D R Budman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D R Budman

Showing results (61-70 of 110) with videos related to

Pageof 11

Sort By:

Cancer Treatment Reports|August 1, 1982

Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B StudyD R Budman, S Ginsberg, M Perry, et al.

Medical and Pediatric Oncology|January 1, 1990

Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353M E Rybak, K McCarroll, R J Kaplan, et al.

Cancer Treatment Reports|June 1, 1985

Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171D R Budman, J Anderson, J P Obrecht, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999

A phase I study of sequential vinorelbine followed by paclitaxelD R Budman, L Weiselberg, V O'Mara, et al.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007

Heparin-induced thrombocytopenia complicating hemodialysisM F Barginear, L Donahue, S L Allen, et al.

Progress in Clinical and Biological Research|January 1, 1986

Comparative cost analysis of home and hospital treatmentV Vinciguerra, T J Degnan, D R Budman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with responseW Kreis, M Lesser, D R Budman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancerJ Aisner, M Y Whitacre, D R Budman, et al.

Cancer Genetics and Cytogenetics|October 1, 1981

A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemiaJ E Kolitz, P Schulman, N Kardon, et al.

Cancer Research|October 1, 1988

Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemiaW Kreis, C Rottach, D R Budman, et al.

Pageof 11

Search research articles

Showing results (61-70 of 110) with videos related to

Sort By:

Pageof 11

Cancer Treatment Reports|August 1, 1982

Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B StudyD R Budman, S Ginsberg, M Perry, et al.

Medical and Pediatric Oncology|January 1, 1990

Cancer Treatment Reports|June 1, 1985

Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171D R Budman, J Anderson, J P Obrecht, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999

A phase I study of sequential vinorelbine followed by paclitaxelD R Budman, L Weiselberg, V O'Mara, et al.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007

Heparin-induced thrombocytopenia complicating hemodialysisM F Barginear, L Donahue, S L Allen, et al.

Progress in Clinical and Biological Research|January 1, 1986

Comparative cost analysis of home and hospital treatmentV Vinciguerra, T J Degnan, D R Budman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with responseW Kreis, M Lesser, D R Budman, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancerJ Aisner, M Y Whitacre, D R Budman, et al.

Cancer Genetics and Cytogenetics|October 1, 1981

A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemiaJ E Kolitz, P Schulman, N Kardon, et al.

Cancer Research|October 1, 1988

Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemiaW Kreis, C Rottach, D R Budman, et al.

Pageof 11